×
89Zr-anti-γH2AX-TAT allows early monitoring of response to gemcitabine and capecitabine therapy in pancreatic ductal adenocarcinoma
Knight J., Mosley M., Constreas Bravo L., Fokas E., Cornelissen B.
Type
Conference paper
Publisher
Journal of Nuclear Medicine
Publication Date
01/05/2016
Volume
57
Pages
333 - 333